Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India
Context: To analyze the results of episcleral plaque brachytherapy using indigenous Bhabha Atomic Research Centre (BARC) Iodine-125 Ocu-Prosta seeds for the management of intraocular tumors from a single institute. AIM: To report our initial experience and learning curve on the use of ′BARC I-125 Oc...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=289;epage=295;aulast=Shah |
id |
doaj-d807f1dac05e49c3985893a34b15d8ce |
---|---|
record_format |
Article |
spelling |
doaj-d807f1dac05e49c3985893a34b15d8ce2020-11-24T22:02:39ZengWolters Kluwer Medknow PublicationsIndian Journal of Ophthalmology0301-47381998-36892012-01-0160428929510.4103/0301-4738.98708Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in IndiaParag K ShahV NarendranU SelvarajP GuhanSanjay K SaxenaAshutosh DashMelvin AstrahanContext: To analyze the results of episcleral plaque brachytherapy using indigenous Bhabha Atomic Research Centre (BARC) Iodine-125 Ocu-Prosta seeds for the management of intraocular tumors from a single institute. AIM: To report our initial experience and learning curve on the use of ′BARC I-125 Ocu-Prosta seeds′ for the management of intraocular tumors such as choroidal melanomas, retinoblastomas and vasoproliferative tumors (VPT). Materials and Methods: We retrospectively reviewed 13 eyes of 13 patients who underwent ophthalmic brachytherapy between May 2008 to March 2012. Nine cases had choroidal melanomas; three had retinoblastomas while one case had VPT. Results: For choroidal melanomas the average apical diameter before brachytherapy was 7.6 mm and average largest basal diameter was 12.1 mm, respectively, which reduced to 4.2 mm and 7.7 mm after the procedure at an average follow-up of 24 months (range 10-43 months). Retinoblastoma and VPT also showed good regression after brachytherapy. Conclusion: Plaque radiotherapy using 125 I seeds can be performed under peribulbar anesthesia and provides a viable option for the management of intraocular cancer with minimal invasiveness and surgical complications. Patients in our studies experienced excellent local tumor control. With the availability of indigenous ′BARC I-125 Ocu-Prosta seeds′ locally, cost effective ophthalmic brachytherapy can be performed in India.http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=289;epage=295;aulast=ShahApoptosisglaucomaintraocular pressureretinal ganglion cellsretinal ischemiatumor necrosis factor-alphaBranch retinal vein occlusionlaserLucentismacular edemaMicrobial etiologymucopurulent keratitissuppurative keratitisIntraoperative application of mitomycin Cmitomycin Cpostoperative complicationspreoperative subconjunctival injectionrecurrence raterecurrent pterygiumCataractinflammationmydriasisprevention and controlsurgeryCross-cylinder techniquephotoastigmatic refractive keratectomyrefractive surgery′BARC I-125 Ocu-Prosta seeds′choroidal melanomaplaque brachytherapyretinoblastomavasoproliferative tumorsAsian Indian |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Parag K Shah V Narendran U Selvaraj P Guhan Sanjay K Saxena Ashutosh Dash Melvin Astrahan |
spellingShingle |
Parag K Shah V Narendran U Selvaraj P Guhan Sanjay K Saxena Ashutosh Dash Melvin Astrahan Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India Indian Journal of Ophthalmology Apoptosis glaucoma intraocular pressure retinal ganglion cells retinal ischemia tumor necrosis factor-alpha Branch retinal vein occlusion laser Lucentis macular edema Microbial etiology mucopurulent keratitis suppurative keratitis Intraoperative application of mitomycin C mitomycin C postoperative complications preoperative subconjunctival injection recurrence rate recurrent pterygium Cataract inflammation mydriasis prevention and control surgery Cross-cylinder technique photoastigmatic refractive keratectomy refractive surgery ′BARC I-125 Ocu-Prosta seeds′ choroidal melanoma plaque brachytherapy retinoblastoma vasoproliferative tumors Asian Indian |
author_facet |
Parag K Shah V Narendran U Selvaraj P Guhan Sanjay K Saxena Ashutosh Dash Melvin Astrahan |
author_sort |
Parag K Shah |
title |
Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India |
title_short |
Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India |
title_full |
Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India |
title_fullStr |
Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India |
title_full_unstemmed |
Episcleral plaque brachytherapy using ′BARC I-125 Ocu-Prosta seeds′ in the treatment of intraocular tumors: A single-institution experience in India |
title_sort |
episcleral plaque brachytherapy using ′barc i-125 ocu-prosta seeds′ in the treatment of intraocular tumors: a single-institution experience in india |
publisher |
Wolters Kluwer Medknow Publications |
series |
Indian Journal of Ophthalmology |
issn |
0301-4738 1998-3689 |
publishDate |
2012-01-01 |
description |
Context: To analyze the results of episcleral plaque brachytherapy using indigenous Bhabha Atomic Research Centre (BARC) Iodine-125 Ocu-Prosta seeds for the management of intraocular tumors from a single institute. AIM: To report our initial experience and learning curve on the use of ′BARC I-125 Ocu-Prosta seeds′ for the management of intraocular tumors such as choroidal melanomas, retinoblastomas and vasoproliferative tumors (VPT). Materials and Methods: We retrospectively reviewed 13 eyes of 13 patients who underwent ophthalmic brachytherapy between May 2008 to March 2012. Nine cases had choroidal melanomas; three had retinoblastomas while one case had VPT. Results: For choroidal melanomas the average apical diameter before brachytherapy was 7.6 mm and average largest basal diameter was 12.1 mm, respectively, which reduced to 4.2 mm and 7.7 mm after the procedure at an average follow-up of 24 months (range 10-43 months). Retinoblastoma and VPT also showed good regression after brachytherapy. Conclusion: Plaque radiotherapy using 125 I seeds can be performed under peribulbar anesthesia and provides a viable option for the management of intraocular cancer with minimal invasiveness and surgical complications. Patients in our studies experienced excellent local tumor control. With the availability of indigenous ′BARC I-125 Ocu-Prosta seeds′ locally, cost effective ophthalmic brachytherapy can be performed in India. |
topic |
Apoptosis glaucoma intraocular pressure retinal ganglion cells retinal ischemia tumor necrosis factor-alpha Branch retinal vein occlusion laser Lucentis macular edema Microbial etiology mucopurulent keratitis suppurative keratitis Intraoperative application of mitomycin C mitomycin C postoperative complications preoperative subconjunctival injection recurrence rate recurrent pterygium Cataract inflammation mydriasis prevention and control surgery Cross-cylinder technique photoastigmatic refractive keratectomy refractive surgery ′BARC I-125 Ocu-Prosta seeds′ choroidal melanoma plaque brachytherapy retinoblastoma vasoproliferative tumors Asian Indian |
url |
http://www.ijo.in/article.asp?issn=0301-4738;year=2012;volume=60;issue=4;spage=289;epage=295;aulast=Shah |
work_keys_str_mv |
AT paragkshah episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia AT vnarendran episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia AT uselvaraj episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia AT pguhan episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia AT sanjayksaxena episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia AT ashutoshdash episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia AT melvinastrahan episcleralplaquebrachytherapyusingbarci125ocuprostaseedsinthetreatmentofintraoculartumorsasingleinstitutionexperienceinindia |
_version_ |
1725834671729672192 |